SCHEMBL26817919

SCHEMBL26817919

COC(=O)[C@H](CCCC(=O)c1ccccc1)NC(=O)[C@@H](C)Cc1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.54
ALDH1A1 P00352 1/20 0.52
THRB P10828 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
HSD17B10 Q99714 1/20 0.52
ERAP2 Q6P179 4/20 0.50
IL1RN P18510 3/20 0.50
MDM4 O15151 1/20 0.47
MDM2 Q00987 1/20 0.47
NPY4R P50391 2/20 0.46
NPY1R P25929 1/20 0.46
LNPEP Q9UIQ6 3/20 0.43
ESRRB O95718 1/20 0.43
ERAP1 Q9NZ08 3/20 0.43
CTSL P07711 1/20 0.43
ACE P12821 1/20 0.42
HDAC1 Q13547 4/20 0.42
HDAC6 Q9UBN7 4/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26817916 0.93 ALDH1A1 (0.59) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL26817967 0.83 ALDH1A1 (0.48) ALDH1A1THRBCYP2C9CYP2C19HSD17B10
SCHEMBL26817913 0.83 ALDH1A1 (0.48) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL26817898 0.83 KMT2A (0.48) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL26817902 0.81 KMT2A (0.46) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL26817931 0.81 KMT2A (0.46) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL26817933 0.79 ALDH1A1 (0.44) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL26817908 0.78 KMT2A (0.43) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL26817750 0.77 TSHR (0.56) TSHRALDH1A1THRBCYP2C9CYP2C19
SCHEMBL930562 0.77 IL1RN (0.57) TSHRALDH1A1THRBCYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING Changzhou University (CN) 2023-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230382946-A1 POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING PTMS, CBS, CHAMP1 TSHR 1863/4885ALDH1A1 1808/4885THRB 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.